James Holm is recorded as CFO at Cronos Group Inc. (CRON). The newest filing on record that lists James Holm as CFO at Cronos Group Inc. (CRON) is dated April 24, 2026. Cronos Group Inc. reported in an 8-K filed March 19, 2025 that James Holm resigned as all positions you hold as an officer or director (or similar or equivalent position) of the Company, Cronos Group or any subsidi, effective March 19, 2025. Cronos Group Inc. reported in an 8-K filed March 19, 2025 that James Holm resigned as Chief Financial Officer of Cronos Group, effective March 19, 2025. Cronos Group Inc. reported in an 8-K filed November 14, 2022 that James Holm was appointed Chief Financial Officer, effective November 14, 2022. The proxy statement of Cronos Group Inc. reports total compensation of $712,289 for James Holm in fiscal 2025, including a base salary of $133,269. Disclosed compensation is on record for 3 fiscal years. James Holm has spoken on 6 earnings calls across 1 company, most recently for Cronos Group Inc. on February 27, 2025. Cronos Group Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Cronos Group Inc. includes Michael Gorenstein (CEO, Chairman and Board Member), Michael Gorenstein Chairman (CEO), Ran Gorelik (Chairman) and 7 others.
“As of the Effective Date, you voluntarily and irrevocably resign from all positions you hold as an officer or director (or similar or equivalent position) of the Company, Cronos Group or any subsidiary thereof (collectively, the “Resignations”).”
Cronos Group Inc. Form 8-K, filed March 19, 2025
· Read the filing
“As of the Effective Date, you voluntarily and irrevocably resign from all positions you hold as an officer or director (or similar or equivalent position) of the Company, Cronos Group or any subsidiary thereof (collectively, the "Resignations").”
Cronos Group Inc. Form 8-K, filed March 19, 2025
· Read the filing
James Holm on recent calls
“In 2024, we increased net revenue 35% year-over-year to $117.6 million with strong performance in Canada and Israel and international markets picking up well. Operating expenses declined by $5 million versus the prior year.”
“I will now review our Third Quarter 2024 Results, which now include the consolidation of GrowCo's financials. The company reported consolidated net revenue of $34.3 million, a 38% increase from the prior year period.”
“I will now review our second quarter 2024 results in relation to the prior year period. The company reported consolidated net revenue of $27.8 million, a 46% increase from the prior year.”
“I will now review our first quarter 2024 results in relation to the prior year period. The company reported consolidated net revenue of $25.3 million, a 30% increase from the prior year period.”
“I will now review our full year 2023 results at a high level before getting into the details of the fourth quarter. In 2023, we increased net revenue 1% year-over-year to $87.2 million with strong performance in Canada and commencement of sales to Germany and Australia, now despite a slowdown in Israel.”
